EN 简
image
Product Candidate1
Technology
Target
Indication
Pre-clinical
Phase I
Phase II/III2
BLA/NDA
image
Product Candidate1
Technology
Target
Indication
Pre-clinical
Phase I
Phase II/III2
BLA/NDA
image
Product Candidate1
Technology
Target
Indication
Pre-clinical
Phase I
Phase II/III2
BLA/NDA
image
Product Candidate1
Technology
Target
Indication
Pre-clinical
Phase I
Phase II/III2
BLA/NDA
for hematologic malignancies
for solid tumors
for autoimmune diseases